obesity

Novo Nordisk in Deal with Kallyope for Obesity, Diabetes Drugs
Yahoo/Zacks.com
Wed, 06/20/18 - 10:20 pm
Novo Nordisk
R&D
Kallyope
diabetes
obesity
Building up its rare obesity pipeline, Rhythm Pharma to raise $150M
Endpoints
Tue, 06/19/18 - 10:53 am
Rhythm Pharmaceuticals
R&D
obesity
Gut Microbes Associated With Obesity May Contribute to Depression and Anxiety
CP Wire
Mon, 06/18/18 - 11:15 am
microbiome
obesity
anxiety
depression
Novo Nordisk's semaglutide spurs major weight loss in phase 2 obesity study
Fierce Pharma
Mon, 03/19/18 - 11:40 pm
Novo Nordisk
obesity
semaglutide
Building on impressive data, Novo Nordisk maps big PhIII obesity program for blockbuster hopeful semaglutide
Endpoints
Tue, 11/21/17 - 11:28 am
Novo Nordisk
obesity
semaglutide
Gelesis touts study of hydrogel obesity drug
Drug Delivery Business News
Mon, 09/25/17 - 11:08 am
Gelesis
obesity
Gelesis100
Rare obesity disease player Rhythm Pharma sets out in search of a $115M IPO windfall
Endpoints
Wed, 09/6/17 - 10:37 am
Rhythm Pharmaceuticals
IPOs
obesity
rare disease
Novo focuses on new obesity therapy Semaglutide
GoInPharma
Tue, 08/15/17 - 09:31 am
Novo Nordisk
obesity
semaglutide
Can Novo’s blockbuster push on obesity drug semaglutide succeed where others failed?
Endpoints
Thu, 08/10/17 - 11:36 am
Novo Nordisk
semaglutide
obesity
Novo Nordisk says obesity drug helps up to 13.8 percent weight loss in phase 2 trial
Reuters
Mon, 06/26/17 - 05:15 pm
Novo Nordisk
obesity
semaglutide
J&J unveils new obesity, arthritis collaborations, shares its molecule library
Fierce Biotech
Thu, 06/15/17 - 09:43 am
JNJ
obesity
rheumatoid arthritis
molecules
molecule library
drug development
Novo Nordisk preps Saxenda sales drive in Latin America after its 'phenomenal' Q1
Fierce Pharma
Tue, 05/23/17 - 08:14 am
Novo Nordisk
Saxenda
Latin America
obesity
Zafgen starts comeback with first data on replacement weight loss drug
Fierce Biotech
Fri, 05/5/17 - 10:27 am
Zafgen
obesity
beloranib
ZGN-1061
Vivus Announces Positive Ruling In Qsymia Litigation - Will It Matter?
Seeking Alpha
Sat, 07/23/16 - 09:58 am
Vivus
Qsymia
obesity
Zafgen shares drop more than 40% as drug focus shifted
Marketwatch
Tue, 07/19/16 - 10:05 pm
Zafgen
beloranib
ZGN-1061
obesity
Arena Pharma stock rises 8.8% after weight-loss drug is approved
Marketwatch
Tue, 07/19/16 - 09:57 am
Arena Pharmaceuticals
FDA
obesity
Eisai
Belviq XR
Arena - Anti-Obesity Drug Lorcaserin Approved In Mexico
Seeking Alpha
Fri, 07/15/16 - 10:21 am
Arena Pharmaceuticals
lorcaserin
obesity
Mexico
Vivus: Qsymia Sales Close Out Q2 With Worst Sales Volume In 2 Years
Seeking Alpha
Mon, 07/11/16 - 09:12 am
Vivus
Qsymia
obesity
Orexigen - Contrave Sales Present Troubling Data
Seeking Alpha
Tue, 06/21/16 - 11:21 am
Orexigen
Contrave
obesity
Vivus - Qsymia Sales Still Trending In The Wrong Direction
Seeking Alpha
Tue, 06/21/16 - 11:19 am
Vivus
Qsymia
obesity

Pages